HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-JUN-15 5BVF
TITLE TETRAHYDROPYRROLO-DIAZEPENONES AS INHIBITORS OF ERK2 KINASE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2,
COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2,
COMPND 6 MAPK 2;
COMPND 7 EC: 2.7.11.24;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS INHIBITOR, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR X.MA,S.STEVEN
REVDAT 2 27-SEP-23 5BVF 1 JRNL REMARK
REVDAT 1 09-SEP-15 5BVF 0
JRNL AUTH J.T.BAGDANOFF,R.JAIN,W.HAN,S.ZHU,A.M.MADIERA,P.S.LEE,X.MA,
JRNL AUTH 2 D.POON
JRNL TITL TETRAHYDROPYRROLO-DIAZEPENONES AS INHIBITORS OF ERK2 KINASE.
JRNL REF BIOORG.MED.CHEM.LETT. V. 25 3788 2015
JRNL REFN ESSN 1464-3405
JRNL PMID 26259804
JRNL DOI 10.1016/J.BMCL.2015.07.091
REMARK 2
REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.9_1692
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.43
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4
REMARK 3 NUMBER OF REFLECTIONS : 28559
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.183
REMARK 3 R VALUE (WORKING SET) : 0.181
REMARK 3 FREE R VALUE : 0.221
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140
REMARK 3 FREE R VALUE TEST SET COUNT : 1468
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 60.4637 - 4.0931 0.99 3002 163 0.1776 0.2025
REMARK 3 2 4.0931 - 3.2489 0.99 2884 158 0.1560 0.1829
REMARK 3 3 3.2489 - 2.8382 1.00 2846 138 0.1775 0.2268
REMARK 3 4 2.8382 - 2.5787 1.00 2810 160 0.1871 0.2542
REMARK 3 5 2.5787 - 2.3939 1.00 2831 146 0.1787 0.2118
REMARK 3 6 2.3939 - 2.2527 1.00 2817 138 0.1819 0.2276
REMARK 3 7 2.2527 - 2.1399 0.99 2803 150 0.1912 0.2472
REMARK 3 8 2.1399 - 2.0467 1.00 2763 154 0.1987 0.2505
REMARK 3 9 2.0467 - 1.9679 0.85 2382 131 0.2411 0.2981
REMARK 3 10 1.9679 - 1.9000 0.71 1953 130 0.2746 0.3130
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.030
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.008 2799
REMARK 3 ANGLE : 1.071 3794
REMARK 3 CHIRALITY : 0.045 410
REMARK 3 PLANARITY : 0.005 502
REMARK 3 DIHEDRAL : 15.577 1050
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): 7.0832 2.5893 19.7890
REMARK 3 T TENSOR
REMARK 3 T11: 0.1059 T22: 0.0948
REMARK 3 T33: 0.1084 T12: 0.0006
REMARK 3 T13: -0.0139 T23: -0.0038
REMARK 3 L TENSOR
REMARK 3 L11: 0.2188 L22: 0.2190
REMARK 3 L33: 0.6551 L12: 0.0697
REMARK 3 L13: -0.0920 L23: 0.3687
REMARK 3 S TENSOR
REMARK 3 S11: 0.0048 S12: -0.0031 S13: -0.0189
REMARK 3 S21: 0.0017 S22: -0.0305 S23: -0.0160
REMARK 3 S31: -0.0319 S32: -0.0377 S33: -0.0000
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5BVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-15.
REMARK 100 THE DEPOSITION ID IS D_1000210595.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-NOV-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28614
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900
REMARK 200 RESOLUTION RANGE LOW (A) : 60.440
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8
REMARK 200 DATA REDUNDANCY : 4.600
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 1ERK
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.65
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20MM MG SULFATE, 20% PEG 3350, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.02800
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.70350
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.03500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.70350
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.02800
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.03500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -2
REMARK 465 PRO A -1
REMARK 465 ALA A 0
REMARK 465 ALA A 1
REMARK 465 ALA A 2
REMARK 465 ALA A 3
REMARK 465 ALA A 4
REMARK 465 ALA A 5
REMARK 465 GLY A 6
REMARK 465 ALA A 172
REMARK 465 ASP A 173
REMARK 465 PRO A 174
REMARK 465 ASP A 175
REMARK 465 HIS A 176
REMARK 465 ASP A 177
REMARK 465 HIS A 178
REMARK 465 THR A 179
REMARK 465 GLY A 180
REMARK 465 PHE A 181
REMARK 465 LEU A 182
REMARK 465 THR A 183
REMARK 465 GLU A 184
REMARK 465 TYR A 185
REMARK 465 VAL A 186
REMARK 465 ALA A 187
REMARK 465 THR A 188
REMARK 465 LEU A 198
REMARK 465 ASN A 199
REMARK 465 SER A 200
REMARK 465 LYS A 201
REMARK 465 GLY A 202
REMARK 465 TYR A 203
REMARK 465 ARG A 357
REMARK 465 SER A 358
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH A 686 O HOH A 688 2.03
REMARK 500 O HOH A 677 O HOH A 684 2.16
REMARK 500 O HOH A 602 O HOH A 649 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ILE A 29 -64.09 -109.55
REMARK 500 TYR A 34 46.77 -145.81
REMARK 500 ASP A 147 40.90 -147.38
REMARK 500 THR A 158 36.05 -98.43
REMARK 500 CYS A 159 15.36 59.92
REMARK 500 ASP A 165 78.56 55.64
REMARK 500 ASN A 251 38.69 -91.79
REMARK 500 LEU A 292 52.97 -96.58
REMARK 500 ASP A 316 83.83 -151.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 709 DISTANCE = 6.15 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 4VJ A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 405
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 406
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5BVD RELATED DB: PDB
REMARK 900 RELATED ID: 5BVE RELATED DB: PDB
DBREF 5BVF A 0 358 UNP P28482 MK01_HUMAN 2 360
SEQADV 5BVF GLY A -2 UNP P28482 EXPRESSION TAG
SEQADV 5BVF PRO A -1 UNP P28482 EXPRESSION TAG
SEQRES 1 A 361 GLY PRO ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU
SEQRES 2 A 361 MET VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR
SEQRES 3 A 361 THR ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET
SEQRES 4 A 361 VAL CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL
SEQRES 5 A 361 ALA ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR
SEQRES 6 A 361 CYS GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG
SEQRES 7 A 361 PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE
SEQRES 8 A 361 ARG ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE
SEQRES 9 A 361 VAL GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU
SEQRES 10 A 361 LYS THR GLN HIS LEU SER ASN ASP HIS ILE CYS TYR PHE
SEQRES 11 A 361 LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER
SEQRES 12 A 361 ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU
SEQRES 13 A 361 LEU LEU ASN THR THR CYS ASP LEU LYS ILE CYS ASP PHE
SEQRES 14 A 361 GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR
SEQRES 15 A 361 GLY PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG
SEQRES 16 A 361 ALA PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS
SEQRES 17 A 361 SER ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU
SEQRES 18 A 361 MET LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR
SEQRES 19 A 361 LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER
SEQRES 20 A 361 PRO SER GLN GLU ASP LEU ASN CYS ILE ILE ASN LEU LYS
SEQRES 21 A 361 ALA ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS
SEQRES 22 A 361 VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS
SEQRES 23 A 361 ALA LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO
SEQRES 24 A 361 HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO
SEQRES 25 A 361 TYR LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE
SEQRES 26 A 361 ALA GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP
SEQRES 27 A 361 LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU
SEQRES 28 A 361 THR ALA ARG PHE GLN PRO GLY TYR ARG SER
HET 4VJ A 401 34
HET SO4 A 402 5
HET SO4 A 403 10
HET SO4 A 404 5
HET SO4 A 405 5
HET SO4 A 406 5
HETNAM 4VJ 2-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-8-(2-{[(1S,
HETNAM 2 4VJ 3R)-3-HYDROXYCYCLOPENTYL]AMINO}PYRIMIDIN-4-YL)-2,3,4,
HETNAM 3 4VJ 5-TETRAHYDRO-1H-PYRROLO[1,2-A][1,4]DIAZEPIN-1-ONE
HETNAM SO4 SULFATE ION
FORMUL 2 4VJ C25 H28 CL N5 O3
FORMUL 3 SO4 5(O4 S 2-)
FORMUL 8 HOH *209(H2 O)
HELIX 1 AA1 HIS A 59 PHE A 76 1 18
HELIX 2 AA2 LEU A 110 GLN A 117 1 8
HELIX 3 AA3 SER A 120 ALA A 141 1 22
HELIX 4 AA4 LYS A 149 SER A 151 5 3
HELIX 5 AA5 LYS A 205 ASN A 222 1 18
HELIX 6 AA6 HIS A 230 GLY A 243 1 14
HELIX 7 AA7 SER A 246 ASN A 251 1 6
HELIX 8 AA8 ASN A 255 LEU A 265 1 11
HELIX 9 AA9 PRO A 272 PHE A 277 1 6
HELIX 10 AB1 ASP A 281 LEU A 292 1 12
HELIX 11 AB2 ASN A 295 ARG A 299 5 5
HELIX 12 AB3 GLU A 301 ALA A 307 1 7
HELIX 13 AB4 HIS A 308 GLU A 312 5 5
HELIX 14 AB5 ASP A 316 GLU A 320 5 5
HELIX 15 AB6 PRO A 337 THR A 349 1 13
HELIX 16 AB7 ALA A 350 GLN A 353 5 4
SHEET 1 AA1 2 MET A 11 VAL A 12 0
SHEET 2 AA1 2 GLN A 15 VAL A 16 -1 O GLN A 15 N VAL A 12
SHEET 1 AA2 5 TYR A 23 GLY A 32 0
SHEET 2 AA2 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24
SHEET 3 AA2 5 VAL A 47 ILE A 54 -1 O LYS A 53 N MET A 36
SHEET 4 AA2 5 VAL A 99 ASP A 104 -1 O ILE A 101 N LYS A 52
SHEET 5 AA2 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102
SHEET 1 AA3 3 THR A 108 ASP A 109 0
SHEET 2 AA3 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108
SHEET 3 AA3 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154
CISPEP 1 GLY A 20 PRO A 21 0 5.56
SITE 1 AC1 18 GLY A 32 TYR A 34 GLY A 35 MET A 36
SITE 2 AC1 18 VAL A 37 ALA A 50 LYS A 52 LYS A 53
SITE 3 AC1 18 ASP A 104 MET A 106 THR A 108 ASP A 109
SITE 4 AC1 18 LYS A 112 ASN A 152 LEU A 154 CYS A 164
SITE 5 AC1 18 ASP A 165 HOH A 598
SITE 1 AC2 4 LYS A 46 HIS A 267 LYS A 340 HOH A 563
SITE 1 AC3 5 GLU A 58 HIS A 59 GLN A 60 THR A 61
SITE 2 AC3 5 LYS A 338
SITE 1 AC4 5 ARG A 189 ARG A 192 HIS A 230 TYR A 231
SITE 2 AC4 5 GLN A 304
SITE 1 AC5 4 THR A 61 ARG A 65 ARG A 146 ARG A 170
SITE 1 AC6 3 ARG A 13 TYR A 28 HOH A 514
CRYST1 44.056 70.070 119.407 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022698 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014271 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008375 0.00000